Literature DB >> 29182605

Prostate cancer: Glycolysis and AR expression as biomarkers.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29182605     DOI： 10.1038/nrurol.2017.205

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Authors:  Josef J Fox; Somali C Gavane; Estelle Blanc-Autran; Sadek Nehmeh; Mithat Gönen; Brad Beattie; Hebert A Vargas; Heiko Schöder; John L Humm; Samson W Fine; Jason S Lewis; Stephen B Solomon; Joseph R Osborne; Darren Veach; Charles L Sawyers; Wolfgang A Weber; Howard I Scher; Michael J Morris; Steven M Larson
Journal:  JAMA Oncol       Date:  2018-02-01       Impact factor: 31.777
  1 in total
  2 in total

1.  MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.

Authors:  Jun Wang; Xiaojuan Li; Zhaoming Xiao; Yu Wang; Yuefu Han; Jun Li; Weian Zhu; Qu Leng; Yuehui Wen; Xinqiao Wen
Journal:  FEBS Open Bio       Date:  2019-08-22       Impact factor: 2.693

2.  Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.

Authors:  Yan Zhang; Mingying Chen; Meihong Liu; Yingkun Xu; Guangzhen Wu
Journal:  Oxid Med Cell Longev       Date:  2021-01-23       Impact factor: 6.543
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.